オンコリスバイオファーマ(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4588/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2020/02/07日証協無担保2,600株-63.38%0株0%12,300株-62.96%
2020/02/07日証協有担保857,604株-4.45%23,700株+30.94%103,100株-18.43%
2020/01/31日証協無担保7,100株+42%0株0%33,206株+23.87%
2020/01/31日証協有担保897,500株-19.82%18,100株-75.31%126,400株-12.16%
2020/01/24日証協無担保5,000株+16.28%0株0%26,808株+59.57%
2020/01/24日証協有担保1,119,400株+46.85%73,300株+120.78%143,900株+258.85%
2020/01/17日証協無担保4,300株0%0株0%16,800株-54.72%
2020/01/17日証協有担保762,300株-34.37%33,200株-72.74%40,100株-79.24%
2020/01/10日証協無担保0株0%0株0%37,101株+236.98%
2020/01/10日証協有担保1,161,500株+191.25%121,800株0%193,200株+8681.82%
2019/12/30日証協無担保0株0%0株0%11,010株-87.4%
2019/12/30日証協有担保398,796株-63.16%0株-100%2,200株-99.1%
2019/12/27日証協無担保0株0%0株0%87,406株+251.03%
2019/12/27日証協有担保1,082,524株+6.61%28,700株-55.3%245,500株+22.44%
2019/12/20日証協無担保0株0%0株0%24,900株-42.63%
2019/12/20日証協有担保1,015,400株-40.29%64,200株+44.37%200,500株+88.26%
2019/12/13日証協無担保0株0%0株-100%43,400株+43.2%
2019/12/13日証協有担保1,700,608株-4.34%44,470株-60.75%106,500株-74.94%
2019/12/06日証協無担保0株0%7,200株0%30,307株+66.51%
2019/12/06日証協有担保1,777,784株0%113,300株0%425,000株-0.61%
2019/11/29日証協無担保0株0%0株0%18,201株-32.84%
2019/11/29日証協有担保1,777,738株+0.41%0株-100%427,600株+580.89%
2019/11/22日証協無担保0株0%0株0%27,101株-4.26%
2019/11/22日証協有担保1,770,400株+3.09%26,700株-42.21%62,800株-66.44%
2019/11/15日証協無担保0株0%0株0%28,306株+21.48%
2019/11/15日証協有担保1,717,396株+89.64%46,200株+31.62%187,100株+89.07%
2019/11/08日証協無担保0株-100%0株0%23,300株-3.74%
2019/11/08日証協有担保905,600株-41.61%35,100株-24.19%98,960株-11.56%
2019/11/01日証協無担保285,100株+9999.99%0株0%24,206株+41.56%
2019/11/01日証協有担保1,551,056株-8.87%46,300株-19.34%111,896株-26.09%
2019/10/25日証協無担保200株0%0株0%17,100株-70.92%
2019/10/25日証協有担保1,702,000株-14.36%57,400株-31.67%151,404株-30.13%
2019/10/18日証協無担保0株0%0株0%58,808株-21.38%
2019/10/18日証協有担保1,987,504株+8.45%84,000株-41.42%216,708株-62%
2019/10/11日証協無担保0株0%0株-100%74,800株+84.23%
2019/10/11日証協有担保1,832,656株+48.21%143,400株+140.2%570,300株+21.21%
2019/10/04日証協無担保0株0%100株0%40,602株+79.65%
2019/10/04日証協有担保1,236,493株+5.68%59,700株-9.13%470,501株+269.89%

※株式分割は考慮していませんのでご注意ください。

Page Top